Genmab
Focus: Genmab is a Netherlands-based biotechnology company specializing in monoclonal antibodies and antibody-drug conjugates for oncology. The company operates as a mid-cap biotech with a focused pipeline centered on hematologic and solid tumor malignancies.
Profile data last refreshed 36m ago · AI intelligence enriched 2mo ago
Open Jobs
145+32 this month
Hot — 134 jobs added in 30d
Net +32 (134 new, 102 removed). Aggressive expansion phase.
Should You Work at Genmab?
AI assessmentStrong fit for oncology-focused professionals seeking exposure to late-stage biologics commercialization with robust pipeline depth, but financial opacity requires due diligence before joining.
Why Work Here
- Commercial momentum: EPKINLY (epcoritamab) is in GROWTH lifecycle with Phase 3 trials ongoing for DLBCL, signaling near-term revenue inflection and marketing opportunity
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
GROWTH
Lead approved product with CD20-directed bispecific antibody mechanism; advancing in Phase 3 for DLBCL expansion and Phase 2 for additional NHL indications.
Products & Portfolio (1)
Help build intelligence for Genmab
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.